896 related articles for article (PubMed ID: 34739696)
1. A short focus, azithromycin in the treatment of respiratory viral infection COVID-19: efficacy or inefficacy?
Vitiello A; Ferrara F
Immunol Res; 2022 Feb; 70(1):129-133. PubMed ID: 34739696
[TBL] [Abstract][Full Text] [Related]
2. Macrolides and viral infections: focus on azithromycin in COVID-19 pathology.
Pani A; Lauriola M; Romandini A; Scaglione F
Int J Antimicrob Agents; 2020 Aug; 56(2):106053. PubMed ID: 32534189
[TBL] [Abstract][Full Text] [Related]
3. Azithromycin: The First Broad-spectrum Therapeutic.
Firth A; Prathapan P
Eur J Med Chem; 2020 Dec; 207():112739. PubMed ID: 32871342
[TBL] [Abstract][Full Text] [Related]
4. Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection.
Khezri MR; Zolbanin NM; Ghasemnejad-Berenji M; Jafari R
Eur J Pharmacol; 2021 Aug; 905():174191. PubMed ID: 34015317
[TBL] [Abstract][Full Text] [Related]
5. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Sivapalan P; Ulrik CS; Bojesen RD; Lapperre TS; Eklöf JV; Håkansson KEJ; Browatzki A; Tidemansen C; Wilcke JT; Janner J; Gottlieb V; Meteran H; Porsbjerg C; Madsen BL; Moberg M; Pedersen L; Benfield TL; Lundgren JD; Knop FK; Biering-Sørensen T; Ghanizada M; Sonne TP; Bødtger UCS; Jensen SG; Rasmussen DB; Brøndum E; Tupper OD; Sørensen SW; Alstrup G; Laursen CB; Møller UW; Sverrild A; Jensen JS
Trials; 2020 Jun; 21(1):513. PubMed ID: 32522282
[TBL] [Abstract][Full Text] [Related]
6. Antiviral effects of azithromycin: A narrative review.
Khoshnood S; Shirani M; Dalir A; Moradi M; Haddadi MH; Sadeghifard N; Birjandi FS; Yashmi I; Heidary M
Biomed Pharmacother; 2022 Mar; 147():112682. PubMed ID: 35131658
[TBL] [Abstract][Full Text] [Related]
7. Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment.
Roden DM; Harrington RA; Poppas A; Russo AM
J Am Coll Cardiol; 2020 May; 75(20):2623-2624. PubMed ID: 32283123
[No Abstract] [Full Text] [Related]
8. Azithromycin in the treatment of COVID-19: a review.
Echeverría-Esnal D; Martin-Ontiyuelo C; Navarrete-Rouco ME; De-Antonio Cuscó M; Ferrández O; Horcajada JP; Grau S
Expert Rev Anti Infect Ther; 2021 Feb; 19(2):147-163. PubMed ID: 32853038
[TBL] [Abstract][Full Text] [Related]
9. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial.
Furtado RHM; Berwanger O; Fonseca HA; Corrêa TD; Ferraz LR; Lapa MG; Zampieri FG; Veiga VC; Azevedo LCP; Rosa RG; Lopes RD; Avezum A; Manoel ALO; Piza FMT; Martins PA; Lisboa TC; Pereira AJ; Olivato GB; Dantas VCS; Milan EP; Gebara OCE; Amazonas RB; Oliveira MB; Soares RVP; Moia DDF; Piano LPA; Castilho K; Momesso RGRAP; Schettino GPP; Rizzo LV; Neto AS; Machado FR; Cavalcanti AB;
Lancet; 2020 Oct; 396(10256):959-967. PubMed ID: 32896292
[TBL] [Abstract][Full Text] [Related]
10. Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine.
Sarayani A; Cicali B; Henriksen CH; Brown JD
Res Social Adm Pharm; 2021 Feb; 17(2):483-486. PubMed ID: 32327397
[TBL] [Abstract][Full Text] [Related]
11. Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel.
Zequn Z; Yujia W; Dingding Q; Jiangfang L
Eur J Pharmacol; 2021 Feb; 893():173813. PubMed ID: 33345848
[TBL] [Abstract][Full Text] [Related]
12. Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection.
Moschini L; Loffi M; Regazzoni V; Di Tano G; Gherbesi E; Danzi GB
Heart Vessels; 2021 Jan; 36(1):115-120. PubMed ID: 32676695
[TBL] [Abstract][Full Text] [Related]
13. Potential pro-arrhythmic effects of pharmacotherapy against SARS-CoV-2.
Medeiros-Domingo A; Carrasco OF; Berni-Betancourt A
Arch Cardiol Mex; 2020; 90(Supl):36-40. PubMed ID: 32523150
[TBL] [Abstract][Full Text] [Related]
14. Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients.
García-Fernández A; Ramos-Ruiz P; Ibáñez-Criado A; Moreno-Pérez Ó; Cambra-Poveda C; Martínez-Martínez JG;
Rev Esp Cardiol (Engl Ed); 2021 Jan; 74(1):108-111. PubMed ID: 33077410
[No Abstract] [Full Text] [Related]
15. Safely Administering Potential QTc Prolonging Therapy Across a Large Health Care System in the COVID-19 Era.
Saleh M; Gabriels J; Chang D; Fishbein J; Qiu M; Mountantonakis SE; Epstein LM;
Circ Arrhythm Electrophysiol; 2020 Nov; 13(11):e008937. PubMed ID: 33003964
[TBL] [Abstract][Full Text] [Related]
16. QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.
Wu TC; Sacilotto L; Darrieux FCDC; Pisani CF; Melo SL; Hachul DT; Scanavacca M
Arq Bras Cardiol; 2020 Jun; 114(6):1061-1066. PubMed ID: 32638906
[No Abstract] [Full Text] [Related]
17. Investigation of QT Prolongation with Hydroxychloroquine and Azithromycin for the Treatment of COVID-19.
Seyhan AU; Doganay F; Yilmaz E; Topal NP; Ak R
J Coll Physicians Surg Pak; 2020 Oct; 30(10):153-157. PubMed ID: 33291194
[TBL] [Abstract][Full Text] [Related]
18. Risk Assessment of Drug-Induced Long QT Syndrome for Some COVID-19 Repurposed Drugs.
Michaud V; Dow P; Al Rihani SB; Deodhar M; Arwood M; Cicali B; Turgeon J
Clin Transl Sci; 2021 Jan; 14(1):20-28. PubMed ID: 32888379
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19.
Gautret P; Lagier JC; Honoré S; Hoang VT; Raoult D
Int J Antimicrob Agents; 2021 Jan; 57(1):106242. PubMed ID: 33408033
[No Abstract] [Full Text] [Related]
20. QT Interval Prolongation Under Hydroxychloroquine/Azithromycin Association for Inpatients With SARS-CoV-2 Lower Respiratory Tract Infection.
Bun SS; Taghji P; Courjon J; Squara F; Scarlatti D; Theodore G; Baudouy D; Sartre B; Labbaoui M; Dellamonica J; Doyen D; Marquette CH; Levraut J; Esnault V; Bun SS; Ferrari E
Clin Pharmacol Ther; 2020 Nov; 108(5):1090-1097. PubMed ID: 32588427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
